Medication Brand Conversion - Zolpidem

posted Aug 24, 2017, 7:19 PM by Izam Ezri Mohd Zakaria   [ updated Aug 24, 2017, 7:26 PM ]
24th August 2017 (Circular No. SP PPUM:  309/2017):

UMMC will soon be supplying patients on oral Zolpidem with "Zopim" tablets by Taiwan Biotech Co. Ltd, Taiwan in place of "Stilnox" tablets by Sanofi-Aventis.

It is categorized as a Standard Formulary item with zero additional charge for supply to paying patients.

Zolpidem 10mg tablet (Zopim)